Galectin Therapeutics (GALT) Interest Coverage Ratio Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,150.63% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 54.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.71% |
| Dec 31, 2025 | 75.91% |
| Sep 30, 2025 | 61.99% |
| Jun 30, 2025 | 71.53% |
| Mar 31, 2025 | 50.63% |
| Dec 31, 2024 | 36.17% |
| Sep 30, 2024 | 44.72% |
| Jun 30, 2024 | 35.76% |
| Mar 31, 2024 | 59.21% |
| Dec 31, 2023 | 67.30% |
| Sep 30, 2023 | 63.64% |
| Jun 30, 2023 | 67.17% |
| Mar 31, 2023 | 48.63% |
| Dec 31, 2022 | -26.47% |
| Sep 30, 2022 | 97.44% |
| Jun 30, 2022 | 56.23% |
| Mar 31, 2022 | 84.76% |
| Dec 31, 2021 | 92.33% |
| Sep 30, 2021 | -337.22% |
| Jun 30, 2021 | 66.83% |
| Mar 31, 2021 | -76.26% |
| Dec 31, 2020 | -50.96% |
| Sep 30, 2020 | -106.99% |
| Jun 30, 2020 | -102.05% |
| Mar 31, 2020 | -51.42% |
| Dec 31, 2019 | -532.01% |
| Sep 30, 2019 | -322.46% |
| Jun 30, 2019 | -225.19% |
| Mar 31, 2019 | -116.31% |